Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Deallus Consulting sees new chief executive
July 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claudio D’Ambrosio, consulting, deallus
Life sciences consultancy firm Deallus Consulting has confirmed its new chief executive is to be Dr Claudio D’Ambrosio. D’Ambrosio succeeds …
Migrants must pay more for treatment on NHS
July 16, 2014Medical Communications, Sales and Marketing NHS, health tourism, migrants
Non-EU citizens will soon have to pay 150% of the cost of treatment on the NHS under new plans announced …
FDA speedy review for new Avastin licence
July 16, 2014Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer
The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …
Hikma completes Bedford Laboratories purchase
July 16, 2014Manufacturing and Production Ben Venue, Boehringer, Hikma, bedford laboratories
Hikma has completed its acquisition of assets of the US generic injectables business Bedford Laboratories from Ben Venue Laboratories, a …
Chiltern acquires Ockham to help lift status
July 16, 2014Manufacturing and Production CRO, chiltern, contract research, fsp, ockham
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both companies look to merge their …
Novartis makes Alzheimer’s deal
July 16, 2014Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein
Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …
Merck Serono appoints R&D global head
July 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Luciano Rossetti, Merck Serono
Merck Serono the biopharma of division of US firm Merck has confirmed the appointment of Luciano Rossetti as its executive …
Novartis forms alliance with Google on ‘smart lens’
July 15, 2014Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable
Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …
Illumina ‘gets 100,000 Genomes contract’
July 15, 2014Manufacturing and Production, Sales and Marketing Cambridge, DNA, DoH, NHS, genomes, illimina
Gene analysis specialist Illumina has been chosen to deliver a project to sequence 100,000 whole genomes from NHS patients by …
UK science minister steps down
July 15, 2014Medical Communications, Sales and Marketing Cameron, UK, Willetts, cabinet, parliament, science minister
The science and universities minister David Willetts has resigned as British prime minister David Cameron carries out a major cabinet …
Targacept admits failure in Alzheimer’s trial
July 15, 2014Research and Development, Sales and Marketing Alzheimer's, Aricept, Pfizer, TC-173, Targacept
Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) …
Mylan buys Abbott generics
July 15, 2014Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan
Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …
UK digital health showcased in China
July 15, 2014Medical Communications, Sales and Marketing China, Shanghai, UK, britain, comms, digital, health
The British government is showcasing its most promising digital health firms at a new centre in China. The “Healthcare is …
Baxter takes R&D head from Merck Serono
July 15, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, baxter, john orloff
Baxter International has appointed Dr John Orloff as its vice president and global head of R&D development for Baxter BioScience. …
Contraceptive microchip tipped to revolutionise birth control
July 14, 2014Medical Communications, Sales and Marketing Bill Gates, MIT, contraceptive, device, implant, microchips
IT start-up company MicroCHIPS is developing a radical new contraceptive in the form of a microchip that is implanted under …
Sun Pharma recalls 40,000 bottles
July 14, 2014Manufacturing and Production Caraco Pharmaceutical Laboratories, FDA, Pfizer/Wyeth’s Effexor XR, Sun Pharma, antidepressant, recall
India-based manufacturer Sun Pharmaceutical Industries is recalling more than 40,000 bottles of its antidepressant venlafaxine hydrochloride, the US regulator has …
AbbVie a step closer to Shire takeover
July 14, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover
Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …
Roche combination drug for melanoma impresses
July 14, 2014Research and Development, Sales and Marketing GSK, Roche, Yervoy, braf, mekinist. MEK, melanoma
Roche’s investigational melanoma drug cobimetinib has helped late-stage patients live longer when used in combination with its established skin cancer …
GSK investigator charged in China
July 14, 2014Medical Communications, Sales and Marketing China, GSK, Witty, bribery, humphrey, sex tape
The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
